Machine learning identifies cancer-driving mutations at CTCF binding sites

FHS
July 8, 2024
2:46 am

Researchers developed a machine learning tool, CTCF-INSITE, to identify mutational hotspots at persistent CTCF binding sites across various cancers, highlighting their role in genomic structure disruption and cancer progression.

The Imperative to Stay the Course on Value-Based Transformation

Courtney Fortner, President and Chief Executive Officer at Navvis Is value-based care still the right strategy to reduce U.S. healthcare costs? Or is it time

September 10, 2024

Optimi Health November 2023 Shareholder Update | Psychedelic Invest

We greatly appreciate your patience and unwavering support as we navigate the intricate landscape of building and expanding our psychedelic supply enterprise. Throughout 2023, our

November 20, 2023

New insights on how melanoma cells resist cancer immunotherapy

Immune checkpoint inhibitors are cancer fighting drugs that help the immune system do its job of detecting and attacking tumor cells.

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.